These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 14405870)

  • 1. Comparison of the reactions induced by psilocybin and LSD-25 in man.
    ISBELL H
    Psychopharmacologia; 1959; 1():29-38. PubMed ID: 14405870
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of psilocin with psilocybin, mescaline and LSD-25.
    WOLBACH AB; MINER EJ; ISBELL H
    Psychopharmacologia; 1962; 3():219-23. PubMed ID: 14007905
    [No Abstract]   [Full Text] [Related]  

  • 3. Cross tolerance between LSD and psilocybin.
    ISBELL H; WOLBACH AB; WIKLER A; MINER EJ
    Psychopharmacologia; 1961; 2():147-59. PubMed ID: 13717955
    [No Abstract]   [Full Text] [Related]  

  • 4. [Psychopsychic correlations under the effect of psycholytics (LSD, psilocybin and similar drugs)].
    HOLFELD H
    Med Exp Int J Exp Med; 1961; 5():209-14. PubMed ID: 13908338
    [No Abstract]   [Full Text] [Related]  

  • 5. d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.
    De Gregorio D; Enns JP; Nuñez NA; Posa L; Gobbi G
    Prog Brain Res; 2018; 242():69-96. PubMed ID: 30471683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models.
    Ezeaka UC; Kim HJJ; Laprairie RB
    Curr Top Med Chem; 2023; 23(23):2232-2241. PubMed ID: 37409550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [THE EXPERIENCE OF ORAL REGRESSION DUE TO THE EFFECT OF HALLUCINOGENS (LSD-25 AND PSILOCYBIN)].
    FERNANDEZ-CERDENO A; LEUNER H
    Z Psychosom Med; 1965; 11():45-54. PubMed ID: 14301325
    [No Abstract]   [Full Text] [Related]  

  • 8. LYSERGIC ACID DIETHYLAMIDE (LSD-25). 34. COMPARISON WITH EFFECT OF PSILOCYBIN ON THE SIAMESE FIGHTING FISH.
    ABRAMSON HA; GETTNER HH; ROLO A; DEAN G
    J Psychol; 1963 Oct; 56():363-74. PubMed ID: 14051981
    [No Abstract]   [Full Text] [Related]  

  • 9. LSD and JB 318: a comparison of two hallucinogens. I. An exploratory study.
    LEBOVITS BZ; VISOTSKY HM; OSTFELD AM
    AMA Arch Gen Psychiatry; 1960 Apr; 2():390-407. PubMed ID: 14415046
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of LSD-25, psiolocybin, and psilocin on temporal lobe EEG patterns and learned behavior in the cat.
    ADEY WR; BELL FR; DENNIS BJ
    Neurology; 1962 Sep; 12():591-602. PubMed ID: 13859403
    [No Abstract]   [Full Text] [Related]  

  • 11. LSD and JB 318: a comparison of two hallucinogens. III. Qualatative analysis and summary of findings.
    LEBOVITS BZ; VISOTSKY HM; OSTEFELD AM
    Arch Gen Psychiatry; 1962 Jul; 7():39-45. PubMed ID: 14463342
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of LSD 25 and JB 318 on tests of visual and perceptual functions in man.
    OSTFELD AM
    Fed Proc; 1961 Dec; 20():876-84. PubMed ID: 14482599
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.
    Ley L; Holze F; Arikci D; Becker AM; Straumann I; Klaiber A; Coviello F; Dierbach S; Thomann J; Duthaler U; Luethi D; Varghese N; Eckert A; Liechti ME
    Neuropsychopharmacology; 2023 Oct; 48(11):1659-1667. PubMed ID: 37231080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [COMPARISON OF PSYCHOPHARMACA LSD-25, BOL-148 AND PSILOCYBIN IN CLINICAL PRACTICE].
    KANDIC B; DORDEVIC D
    Vojnosanit Pregl; 1963 May; 20():275-9. PubMed ID: 14067329
    [No Abstract]   [Full Text] [Related]  

  • 15. Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.
    Koerner J; Appel JB
    Psychopharmacology (Berl); 1982; 76(2):130-5. PubMed ID: 6805022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mescaline, LSD, psilocybin, and personality change.
    UNGER SM
    Psychiatry; 1963 May; 26():111-25. PubMed ID: 13995386
    [No Abstract]   [Full Text] [Related]  

  • 17. EEG effects of hallucinogens and cannabinoids using sleep-waking behavior as baseline.
    Fairchild MD; Jenden DJ; Mickey MR; Yale C
    Pharmacol Biochem Behav; 1980 Jan; 12(1):99-105. PubMed ID: 6102770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains.
    Varley TF; Carhart-Harris R; Roseman L; Menon DK; Stamatakis EA
    Neuroimage; 2020 Oct; 220():117049. PubMed ID: 32619708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The possible role of tryptamine in brain function and its relationship to the actions of LSD-like hallucinogens.
    Martin WR; Sloan JW
    Mt Sinai J Med; 1974; 41(2):276-82. PubMed ID: 4544624
    [No Abstract]   [Full Text] [Related]  

  • 20. [A PSYCHOPATHOLOGICAL STUDY OF THE PSILOCYBIN PSYCHOSIS; COMPARISON WITH THE LSD-25 PSYCHOSIS].
    MIYOSHI A
    Seishin Shinkeigaku Zasshi; 1964 Oct; 66():826-36. PubMed ID: 14286595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.